Amneal Pharmaceuticals, Inc.
AMRX
DELAYED 1 MONTH

21 insider filings · Latest: May 11, 2026

Common Stock Transactions
Txn DateAcceptedInsiderTypeSharesAvg PriceValueShares OwnedFiling
May 11, 2026May 12 8:10 PMDeborah M. AutorDirector
Sale
34,819$12.94$450.6K93,660(D)

View →

Stock Options & Derivatives
Txn DateAcceptedInsiderTypeSharesExercise PriceShares OwnedFiling
Mar 4, 2026Mar 5 9:32 PMJason B. DalyEVP, Chief Legal Officer
Option Exercise
35,880—71,760(D)

View →

Mar 3, 2026Mar 5 9:32 PMJason B. DalyEVP, Chief Legal Officer
Option Exercise
390,939—0(D)

View →

Mar 4, 2026Mar 5 9:31 PMTasos KonidarisExecutive Vice President & CFO
Option Exercise
49,982—87,963(D)

View →

Mar 3, 2026Mar 5 9:31 PMTasos KonidarisExecutive Vice President & CFO
Option Exercise
589,883—0(D)

View →

Mar 4, 2026Mar 5 9:31 PMAndrew S BoyerExecutive Vice President
Option Exercise
38,195—76,389(D)

View →

Mar 3, 2026Mar 5 9:31 PMAndrew S BoyerExecutive Vice President
Option Exercise
510,758—0(D)

View →

Mar 4, 2026Mar 5 9:30 PMNikita ShahExecutive Vice President
Option Exercise
35,880—71,760(D)

View →

Mar 3, 2026Mar 5 9:30 PMNikita ShahExecutive Vice President
Option Exercise
472,619—0(D)

View →

Mar 2, 2026Mar 3 9:29 PMPatel ChintuDirector, Co-CEO
Grant/Award
544,663—354,031(D)

View →

Mar 2, 2026Mar 3 9:29 PMPatel Chirag K.Director, President & Co-CEO
Grant/Award
544,663—354,031(D)

View →

Mar 2, 2026Mar 3 9:28 PMNikita ShahExecutive Vice President
Grant/Award
130,718—65,359(D)

View →

Mar 2, 2026Mar 3 9:28 PMTasos KonidarisExecutive Vice President & CFO
Grant/Award
145,244—72,622(D)

View →

Mar 2, 2026Mar 3 9:27 PMJason B. DalyEVP, Chief Legal Officer
Grant/Award
130,718—65,359(D)

View →

Mar 2, 2026Mar 3 9:26 PMAndrew S BoyerExecutive Vice President
Grant/Award
130,718—65,359(D)

View →

← Previous

Page 2 of 2